Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
In laboratory tests, the levels of serum albumin (P = 0.014), serum calcium (P = 0.050), and serum total 25-hydroxyvitamin D (P < 0.001) were significantly different among the quartile groups.Calculation process of DII.Characteristics of study participants according to DII.VariablesOverallDIIP value(N = 526)Q1 (N = 131)Q2 (N = 132)Q3 (N = 131)Q4 (N = 132)DII, min ~ max − 5.41 ~ 4.23 − 5.41 ~ − 1.22 − 1.22 ~ − 0.02 − 0.02 ~ 1.211.21 ~ 4.23Male (n, %)229 (43.5%)47 (35.9%)a67 (50.8%)46 (35.1%)b69 (52.3%)ab0.003**Age, y63.25 ± 11.3366.07 ± 10.57ab64.55 ± 11.03c62.41 ± 11.56a60.01 ± 11.33bc < 0.001**Race (n, %)0.197 Mexican American54 (10.3%)10 (7.6%)17 (12.9%)19 (14.5%)8 (6.1%) Other Hispanic40 (7.6%)11 (8.4%)13 (9.8%)9 (6.9%)7 (5.3%) Non-Hispanic White208 (39.5%)52 (39.7%)47 (35.6%)52 (39.7%)57 (43.2%) Non-Hispanic Black156 (29.7%)33 (25.2%)33 (25.0%)40 (30.5%)50 (37.9%) Other Race68 (12.9%)25 (19.1%)22 (16.7%)11 (8.4%)10 (7.6%)Income (n, %)0.500 Not poor106 (20.2%)27 (20.6%)22 (16.7%)25 (19.1%)32 (24.2%) Near poor233 (44.3%)49 (37.4%)59 (44.7%)64 (48.9%)61 (46.2%) Poor187 (35.6%)55 (42.0%)51 (38.6%)42 (32.1%)39 (29.5%)BMI, kg/m20.433 < 25.0102 (19.5%)24 (18.5%)28 (21.3%)26 (20.0%)24 (18.4%) 25.0 ~ 30146 (27.9%)45 (34.6%)37 (28.0%)31 (23.8%)33 (25.2%) ≥ 30275 (52.6%)61 (46.9%)67 (50.8%)73 (56.2%)74 (56.5%)Smoking (n, %)245 (46.6%)44 (33.6%)ab70 (53.0%)a62 (47.3%)69 (52.3%)b0.005**Drinking (n, %)153 (51.0%)22 (36.1%)ab35 (45.5%)44 (54.3%)a52 (64.2%)b0.006**Hypertension (n, %)340 (64.9%)84 (64.1%)85 (64.9%)79 (60.8%)92 (69.7%)0.503Diabetes (n, %)162 (30.9%)41 (31.3%)45 (34.1%)33 (25.2%)43 (32.8%)0.406Cardiovascular disease (n, %)48 (9.1%)8 (6.1%)12 (9.1%)16 (12.2%)12 (9.1%)0.389Malignant tumor (n, %)83 (15.8%)21 (16.0%)18 (13.6%)24 (18.3%)20 (15.2%)0.768Stroke (n, %)46(8.7%)10 (7.6%)6 (4.5%)15 (11.5%)15 (11.4%)0.141eGFR, ml/min61.11 [53.39, 84.69]60.59 [52.94, 77.65]65.26 [54.04, 87.92]60.16 [53.03, 91.03]61.34 [54.50, 82.66]0.714ACR, mg/g0.890 A1179 (34.0%)47 (35.9%)43 (32.6%)50 (38.2%)39 (29.5%) A2286 (54.4%)70 (53.4%)69 (52.3%)68 (51.9%)79 (59.8%) A361 (11.6%)14 (10.7%)20 (15.2%)13 (9.9%)14 (10.6%)Hemoglobin, g/L13.59 ± 1.6213.46 ± 1.7213.75 ± 1.5013.41 ± 1.3913.75 ± 1.820.171NLR2.06 [1.50, 2.82]1.95 [1.46, 2.53]2.18 [1.58, 2.82]2.00 [1.54, 2.71]2.18 [1.41, 3.09]0.442Albumin, g/L40.89 ± 3.3241.64 ± 3.09ab40.56 ± 3.77a40.93 ± 2.9940.43 ± 3.26b0.014*Calcium, mmol/L2.36 ± 0.102.38 ± 0.12a2.35 ± 0.092.35 ± 0.09a2.36 ± 0.100.050*Phosphorus, mmol/L1.20 ± 0.191.22 ± 0.181.21 ± 0.201.18 ± 0.181.19 ± 0.190.418Uric acid, μmol/L339.00 [285.50, 413.40]339.00 [279.60, 395.55]336.05 [284.02, 404.50]339.00 [291.50, 410.40]356.90 [282.55, 428.30]0.566Total 25-hydroxyvitamin D, mmol/L71.35 [50.12, 97.90]83.70 [61.95, 105.50]abc70.70 [47.77, 94.67]a69.90 [51.45, 97.25]b59.30 [41.38, 86.88]c < 0.001**Total hip BMD, g/cm20.92 ± 0.170.89 ± 0.15a0.93 ± 0.170.92 ± 0.180.94 ± 0.16a0.048*Femoral neck BMD, g/cm20.76 ± 0.150.74 ± 0.140.76 ± 0.160.76 ± 0.150.78 ± 0.140.153Lumbar spine BMD, g/cm21.01 ± 0.180.99 ± 0.161.02 ± 0.181.02 ± 0.201.03 ± 0.180.186Osteoporosis (n, %)133 (25.3%)41 (31.3%)31 (23.5%)30 (22.9%)31 (23.5%)0.356Calcium intake, mg/d688.50 [460.50, 1073.75]706.00 [502.00, 1123.00]678.00 [476.75, 1048.25]674.00 [426.50, 1112.00]726.50 [429.75, 1050.75]0.828Phosphorus intake, mg/d1137.00 [794.50, 1578.00]1091.00 [795.50, 1547.50]1173.50 [846.50, 1607.00]1079.00 [788.00, 1547.00]1172.00 [751.00, 1569.25]0.764Steroids use (n, %)44 (8.4%)7 (5.3%)11 (8.4%)10 (7.7%)16 (12.2%)0.262Estrogen (n,%)80(15.2%)23(17.6%)17(12.9%)23(17.6%)17(12.9%)0.526Anti-osteoporosis drugs (n,%)38(7.2%)13 (9.9%)12(9.1%)7(5.3%)6(4.5%)0.239Physical activity (n, %)141(26.8%)35 (26.7%)34 (25.8%)32 (24.4%)40 (30.3%)0.735DII Dietary inflammatory index; BMI Body mass index; eGFR Estimated glomerular filtration rate; NLR Neutrophil to lymphocyte ratio; ACR Albumin to creatinine ratio (A1, ACR < 30 mg/g; A2, ACR 30 to 300 mg/g; A3, ACR > 300 mg/g); BMD Bone mineral density; Total 25-Hydroxyvitamin D: the sum of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3, but excludes epi-25-hydroxyvitamin D3; a, b, cstatistically significance between 2 groups using the Bonferroni method; *p < 0.05; **p < 0.01.
Source: Characteristics of study participants. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The average age of participants was 63.25 years.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The relationship between dietary inflammatory index and osteoporosis among chronic kidney disease population
Study design awaiting verification · Scientific Reports · 2023
Original publication title
The relationship between dietary inflammatory index and osteoporosis among chronic kidney disease population
© The Author(s) 2023
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Dietary inflammation index (DII) is an epidemiological survey tool to evaluate dietary inflammation potential. Osteoporosis, whose development is deeply affected by inflammation, may be also affected by dietary inflammatory patterns. However, the relationship between DII and osteoporosis is unclear for chronic kidney disease (CKD) population. Our study involved 526 CKD patients from the US National Health and Nutrition Examination Survey (NHANES). DII levels were stratified into four quantile groups. Multivariable regression models were used to examine the association between DII and osteoporosis.
Restricted cubic splines and subgroup analysis were additionally adopted. Results showed that the overall prevalence of osteoporosis among CKD patients was 25.3%. After fully adjusted, OR (95% confidence interval) for Q4 group compared with Q3 (reference group) in total and female population were 2.09 (1.05, 4.23) and 2.80 (1.14, 7.08), respectively. Subgroup analysis indicated that these results had no interaction with age, gender, body mass index (BMI), renal function, urinary protein, calcium, phosphorus and total 25-hydroxyvitamin D. DII was negatively correlated with lumbar spine bone mineral density (BMD) in CKD population (P < 0.05).
Therefore, in CKD patients, higher DII was associated with higher osteoporosis risk and lower BMD of lumber spine, especially in female. Anti-inflammatory diet patterns may be a protective intervention for some CKD-related osteoporosis.
Authors’ abstract
Dietary inflammation index (DII) is an epidemiological survey tool to evaluate dietary inflammation potential. Osteoporosis, whose development is deeply affected by inflammation, may be also affected by dietary inflammatory patterns. However, the relationship between DII and osteoporosis is unclear for chronic kidney disease (CKD) population. Our study involved 526 CKD patients from the US National Health and Nutrition Examination Survey (NHANES). DII levels were stratified into four quantile groups. Multivariable regression models were used to examine the association between DII and osteoporosis.
Restricted cubic splines and subgroup analysis were additionally adopted. Results showed that the overall prevalence of osteoporosis among CKD patients was 25.3%. After fully adjusted, OR (95% confidence interval) for Q4 group compared with Q3 (reference group) in total and female population were 2.09 (1.05, 4.23) and 2.80 (1.14, 7.08), respectively. Subgroup analysis indicated that these results had no interaction with age, gender, body mass index (BMI), renal function, urinary protein, calcium, phosphorus and total 25-hydroxyvitamin D. DII was negatively correlated with lumbar spine bone mineral density (BMD) in CKD population (P < 0.05).
Therefore, in CKD patients, higher DII was associated with higher osteoporosis risk and lower BMD of lumber spine, especially in female. Anti-inflammatory diet patterns may be a protective intervention for some CKD-related osteoporosis.
Publication and source details
Original title: The relationship between dietary inflammatory index and osteoporosis among chronic kidney disease population
Xinxuan Meng; Wenxin Sha; Xiaowei Lou; Jianghua Chen
Scientific Reports · 2023
© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Scientific Research Fund of Zhejiang Provincial Education DepartmentRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T05:35:56.982741+00:00
DOI: 10.1038/s41598-023-49824-5 · PMC10739725